Patent directory · USPTO A61K / A61P
Patents matching “COAG”
29 pharma patents match "COAG" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 29 pharmaceutical patents matching "COAG" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12331297
Coagulation factor V (F5) iRNA compositions and methods of use thereof
granted -
US 12240914
Antibody against factor XIa in activated form of coagulant factor XI, preparation method therefor and use thereof
granted -
US 12102642
Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators
granted -
US 11547663
Unit aerosol doses for anticoagulation
granted -
US 11524013
Treatment of hypercoagulopathy in Cushing's syndrome by administration of glucocorticoid receptor modulators
granted -
US 11261437
Procoagulant compounds
granted -
US 11066481
Antibodies to coagulation factor XIa and uses thereof
granted -
US 11040109
Blood coagulation protein conjugates
granted -
US 10668015
Unit aerosol doses for anticoagulation
granted -
US 10588940
Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders
granted -
US 10584147
Procoagulant fusion compound
granted -
US 10407488
Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation
granted -
US 10287564
Procoagulant compounds
granted -
CA 3046406
PRODUIT DE REMPLACEMENT DE FACTEUR DE COAGULATION SANGUINE POUR UTILISATION DANS LE TRAITEMENT PROPHYLACTIQUE OU THERAPEUTIQUE DES HEMORRAGIES
granted -
US 9938272
Hydrazine compound as blood coagulation factor Xa inhibitor
granted -
US 9249115
N,N1 substituted piperazines having combined antiaggregant, anticoagulant and vasodilatory activity, and method for producing same
granted -
US 8426433
Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution
granted -
US 8383388
Modified coagulation factor IX polypeptides and use thereof for treatment
granted -
US 8187591
Methods of treating coagulopathy
granted -
US 7951356
Tissue factor compositions and kits for coagulation and tumor treatment
granted -
US 7691380
Combined methods for tumor coagulation and tumor treatment
granted -
US 7202087
Anticoagulant composition
granted -
US 7101557
Combined tissue factor methods for coagulation and tumor treatment
granted -
US 6749853
Combined methods and compositions for coagulation and tumor treatment
expired